4.6 Review

MSP: An emerging player in metabolic syndrome

Journal

CYTOKINE & GROWTH FACTOR REVIEWS
Volume 26, Issue 1, Pages 75-82

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.cytogfr.2014.10.007

Keywords

MSP; RON; Inflammation; Metabolic syndrome

Funding

  1. Netherlands Organization for Scientific Research (NWO) (VIDI grant) [864.10.007, 016.126.327]
  2. Chinese Scholarship Council [201307040028]
  3. Marie Curie fellowship [PIIF-GA-2012-332230]
  4. Maag Lever Darm Stichting (MLDS) [WO 08-16, WO 11-35]

Ask authors/readers for more resources

MSP (Macrophage Stimulating Protein; also known as Hepatocyte Growth Factor-like protein (HGFL) and MST1) is a secreted protein and the ligand for transmembrane receptor tyrosine kinase Recepteur d'Origine Nantais (RON; also known as MST1R). Since its discovery, MSP has been demonstrated to play a key role in regulating inflammation in the peripheral tissues of multiple disease models. Recent evidences also point toward a beneficial role of MSP in the regulation of hepatic lipid and glucose metabolism, thereby implicating MSP as a crucial regulator in maintaining metabolic homeostasis while simultaneously suppressing inflammatory processes. In this review, we discuss the recent advances that demonstrate the significance of MSP in metabolic syndrome and build a strong case supporting its therapeutic potential. (C) 2014 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available